2.0
16. Aug. 2013
Aktueller Mitarbeiter
Boston, MA
Empfehlen
CEO-Befürwortung
Geschäftsprognose
Pros
Many smart scientists still work at Merck, especially below the Executive Director, and probably below the Director levels.
Kontras
Instability over the last 5 years that leads to direction changes every 8 months (especially in Oncology). Complete incompetence and lack of any vision at the highest management levels (people like Rich Tillyer) -- they use the company to exercise their huge egos, while destroying any real science and innovation. A lot of incompetence at the lower management levels (Executive Directors, Directors). Extreme inefficiency of the decision making process -- all power brokers need to be satisfied, leading to bad decisions. Good scientist and good science are not respected.